Balaji Amines Limited, a leading manufacturer of Aliphatic Amines in India, has announced commissioning of a greenfield project along with construction of 2 new plants.

The Phase 1 of 90-acre Greenfield Project (Unit IV) has been completed and the Di-methyl Carbonate (DMC)/Propylene Carbonate (PC) and Propylene Glycol (PG) Plant will be ready to commence commercial production by the end of September 2022.

This is estimated to result in annual production capacity of 15,000 tons of Di-methyl Carbonate (DMC)/Propylene Carbonate (PC) and 15,000 tons Propylene Glycol (PG). This will also provide a strategic advantage of being the sole manufacturer of Di-methyl Carbonate (DMC) and Propylene Carbonate (PC) in India.

Currently the annual domestic demand of Di-methyl Carbonate is about 8,000 to 9,000 tons with main usage in pharma and others, Propylene Glycol is about 170,000 to 180,000 tons & Propylene Carbonate is about 3,000 to 4,000 tons which are completely met by imports. DMC is also used in the production of Polycarbonate and Lithium batteries – the consumption of which will exponentially grow in India backed by various government initiatives. In the first year of operations, the company is confident of achieving capacity utilization of 60-70% at the DMC/PC and PG plant.

The company has also started construction in Phase 2 of the Greenfield Project (Unit IV) for below 2 plants. The environmental clearance for the same has been received well in advance. The company expects to start operations at these state-of-the-art manufacturing facilities around the closure of this current financial year.

Commenting on the developments D. Ram Reddy, Managing Director, Balaji Amines Limited said, “We are proud to announce successful completion of Phase 1 of the greenfield project. This will enable us to explore greater opportunities as we will be the sole supplier for DMC/PC in India, which we believe has good demand in the domestic market and will also have potential for exporting to Global markets."

"Further, we are now gearing up for the expansion in Phase 2 of the Greenfield Project (Unit IV), for which construction activities are in full swing. The products Methyl Amine & DMAHCL will be manufactured with an upgraded/improved technology which will enable us to compete in the global market. The Capex for these plants would be around Rs. 200 - 220 crore which will be funded entirely by internal accruals. Currently Balaji Amines Ltd. is a zero-debt company on a standalone basis. We are excited to undertake further strategic initiatives to add incremental capacity and build upon our strength,” added Reddy.